BEST UNLIMITED TURBO LONG CERTIFICATE - EDWARDS LIFESCIENCES

BEST UNLIMITED TURBO LONG CERTIFICATE - EDWARDS LIFESCIENCES Share Price

395CS

DE000SU1DHN3

Real-time Euronext Paris 10:08:36 13/05/2024 BST
6.38 ^EUR	-0.47%

Current month	+4.85%
1 month	-12.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart EDWARDS LIFESCIENCES CORPORATION

Chart BEST UNLIMITED TURBO LONG CERTIFICATE - EDWARDS LIFESCIENCES

Latest news about EDWARDS LIFESCIENCES CORPORATION

Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	05-09	BU
Edwards Lifesciences Corporation Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	05-09	CI
Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100	05-07	MT
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	05-01	MT

More news

Quotes 5-day view

Date	Price	Change	Volume
13/05/24	6.38	-0.47%	13
10/05/24	6.48	+1.09%	43
09/05/24	6.41	+4.40%	50
08/05/24	6.14	-2.07%	56
07/05/24	6.27	+2.45%	66

Real-time Euronext Paris

Last update May 13, 2024 at 10:08 am

More quotes

Static data

Product type	Knock-Out without Stop Loss
Buy / Sell	CALL
Underlying	EDWARDS LIFESCIENCES CORPORATION
Issuer	Société Générale
	395CS
ISIN	DE000SU1DHN3
Date issued	30/10/2023
Strike	52.86 $
Maturity	Unlimited
Parity	5 : 1
Emission price	2.57 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	8.23 €
Lowest since issue	2.07 €
Spread	0.15 €
Spread %	2.32%

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).

Sector

More about the company

Ratings for Edwards Lifesciences Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Consensus: Edwards Lifesciences Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

86.72 USD

Average target price

95.27 USD

Spread / Average Target

+9.86%

Consensus